Skip to main content

GOLDMAN SACHS GROUP INC

Position in SLN — Silence Therapeutics plc

CIK 886982 NEW YORK, NY

Position in SLN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,712,100
+$1,435,368 QoQ
Shares Held
155,929
+196.9% QoQ
Ownership
0.251%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#30
of 72 holders
Holding Since
Dec 2021
17 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SLN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,040,376,854 across 359 Biotechnology names. SLN ranks #233 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in SLN

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,712,100 155,929
2026-03-31 $276,732 52,511
2025-12-31 $110,133 18,114
2025-09-30 $117,522 22,644
2025-03-31 $68,737 24,375
2024-12-31 $253,768 36,885
2024-09-30 $556,889 30,632
2024-06-30 $308,864 16,256
2024-03-31 $469,562 21,739
2023-09-30 $2,618,669 266,667
2023-06-30 $2,255,000 410,000
2023-03-31 $4,092,000 660,000
2022-12-31 $10,067,882 660,189
2022-09-30 $6,623,100 660,000
2022-06-30 $7,821,000 660,000
2022-03-31 $18,350,485 965,815
2021-12-31 $18,156,400 760,000